Canada’s CGPA Welcomes Move Towards National Pharmacare
Budget Announcement Commits To Legislation By The End Of Next Year
A renewed commitment from Canada’s government to a universal national pharmacare program, included in the latest federal budget, has been welcomed by the country’s generics and biosimilars industry.
